The company’s turnover increased to RON52.92 million (EUR12 million), from RON49.48 million).
Revenues stood at RON55.88 million after six months, 6.4% more than in the same period of 2011, while expenses climbed by 4.2%, to RON40.58 million.
Romanian regional investment funds SIF Oltenia (SIF5. RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 57% of Biofarm’s shares.
Biofarm shares were most recently traded at RON0.1824 per share on the Bucharest stock exchange. (EUR1=RON4.5186)